Hansoh Pharmaceutical Group Company Limited
HKEX:3692.HK
17.7 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 3,766.155 | 2,583.747 | 2,712.902 | 2,568.907 | 2,556.742 | 2,309.325 | 1,932.791 | 1,804.278 |
| Depreciation & Amortization
| 366.381 | 344.602 | 278.467 | 228.23 | 189.561 | 159.096 | 138.013 | 121.302 |
| Deferred Income Tax
| 0 | -228.919 | 595.622 | 698.831 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 171.365 | 179.416 | 65.472 | 68.59 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 257.232 | 49.503 | -661.094 | -767.421 | 457.578 | -43.858 | -412.954 | -358.48 |
| Accounts Receivables
| 341.758 | 90.446 | -549.347 | -881.192 | 400.251 | -455.256 | -466.275 | -691.989 |
| Inventory
| -129.537 | -40.943 | -111.747 | 113.771 | 57.327 | -33.115 | -78.397 | -95.021 |
| Accounts Payables
| 0 | 332.147 | -282.256 | -464.522 | -336.676 | 455.256 | 466.275 | 691.989 |
| Other Working Capital
| 90.17 | -332.147 | 282.256 | 464.522 | 336.676 | -10.743 | 131.718 | 428.53 |
| Other Non Cash Items
| -740.457 | -187.144 | -414.307 | -406.658 | 125.808 | -352.336 | -255.598 | -320.593 |
| Operating Cash Flow
| 3,116.468 | 2,741.205 | 2,577.062 | 2,390.479 | 3,329.689 | 2,072.227 | 1,402.252 | 1,246.507 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -362.524 | -272.821 | -460.033 | -1,427.645 | -592.476 | -407.216 | -263.087 | -273.489 |
| Acquisitions Net
| 10.821 | -66.646 | 1,988.904 | 1,506.195 | 6,596.882 | 0.671 | 6.741 | 15.825 |
| Purchases Of Investments
| -1,392.492 | -6,311.013 | -9,391.412 | -5,740.484 | -6,658.418 | -11,247.831 | -4,744.742 | -4,773.134 |
| Sales Maturities Of Investments
| 2,265.583 | 602.14 | 7,402.508 | 4,234.289 | 61.536 | 10,257.372 | 4,390.156 | 5,857.146 |
| Other Investing Activites
| 1,293.57 | 113.267 | -1,799.124 | -1,446.482 | -6,483.123 | 8.26 | -3.339 | 3.19 |
| Investing Cash Flow
| 1,073.972 | -5,935.073 | -2,259.157 | -2,874.127 | -7,075.599 | -1,388.744 | -614.271 | 829.538 |
| Financing Activities: | ||||||||
| Debt Repayment
| -18.963 | -42.485 | -12.289 | -7.601 | -41.668 | 0 | 0 | -450 |
| Common Stock Issued
| -76.878 | -63.475 | -42.858 | 3,171.973 | 9,534.396 | 0 | 0 | 1,302.449 |
| Common Stock Repurchased
| -114.865 | -76.618 | -57.969 | -3,164.372 | -9,492.728 | 0 | 0 | 396.583 |
| Dividends Paid
| -652.082 | -712.184 | -380.866 | -4,200 | -1,500 | 0 | -404.134 | -2,368.507 |
| Other Financing Activities
| 32.215 | 76.618 | 3,910.758 | 3,164.372 | 9,492.728 | 0 | -326.341 | -929.083 |
| Financing Cash Flow
| -753.695 | -818.144 | 3,416.776 | -1,035.628 | 7,992.728 | 0 | -730.475 | -2,048.558 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| -122.364 | -40.565 | -79.288 | -762.267 | 133.21 | 14.904 | 0.239 | 20.02 |
| Net Change In Cash
| 3,314.381 | -4,052.577 | 3,655.393 | -2,281.543 | 4,380.028 | 698.387 | 57.745 | 47.507 |
| Cash At End Of Period
| 5,980.513 | 2,666.132 | 6,718.709 | 3,063.316 | 5,344.859 | 964.831 | 266.444 | 208.699 |